Biotia secured an oversubscribed $9M financing to scale its NYC lab and expand diagnostics in women's health and orthopedics.
TETmedical appointed diagnostics commercialization executive Arjun Ishwar as chief commercial officer as NSE-FAST advances toward pivotal study.
A peer-reviewed preclinical study found AVA-003 outperformed chlorhexidine against Candida auris on skin, advancing AvantGuard’s development program.
FedEx ordered 2,000 Harbinger electric trucks in a deal valued at more than $300 million, with deliveries planned by end of 2027.
ChipLytics raised $4.5 million and opened a Bellport inspection lab to help detect counterfeit and suspect electronic components.
TETmedical adds Marc Lebel and Patrick McBrayer to its board as it advances a pivotal study and financing for its rapid stroke diagnostic.
